Subject assessment | Treatment group | Control group | P value* | ||
---|---|---|---|---|---|
n | Score | n | Score | ||
OSDI questionnaire score (mean ± SD) | |||||
Baseline | 90 | 41.8 ± 20.8 | 90 | 44.8 ± 20.9 | 0.2116 |
At day 7 | 85 | 15.6 ± 16.8 | 85 | 18.1 ± 19.5 | 0.4934 |
At day 30 | 83 | 12.7 ± 11.3 | 82 | 14.2 ± 13.8 | 0.7243 |
Change from baseline at day 7 | 85 | −26.7 ± 20.3** | 85 | −27.2 ± 22.7*** | 0.7447 |
Change from baseline at day 30 | 83 | −29.9 ± 19.4*** | 82 | −30.8 ± 20.6*** | 0.7748 |
Subjective symptom evaluation score (mean ± SD) | |||||
Baseline | 90 | 11.8 ± 6.2 | 90 | 11.5 ± 6.0 | 0.7700 |
At day 7 | 85 | 6.1 ± 5.3 | 85 | 6.4 ± 5.2 | 0.4737 |
At day 30 | 83 | 5.1 ± 3.6 | 82 | 5.6 ± 4.0 | 0.5971 |
Change from baseline at day 7 | 85 | −5.9 ± 5.2** | 85 | −5.4 ± 5.6*** | 0.9018 |
Change from baseline at day 30 | 83 | −7.0 ± 4.7** | 82 | −6.2 ± 5.8*** | 0.6069 |